Clifford Chance and Sullivan & Cromwell lead as Cinven sells Amdipharm Mercury
September 09, 2015 at 04:55 AM
1 minute read
The original version of this story was published on Legalweek
Clifford Chance and Sullivan & Cromwell are leading a group of firms on buy-out house Cinven’s sale of UK-based pharmaceuticals company Amdipharm Mercury (AMCo).
Canada-based Concordia Healthcare has entered into a deal with Cinven to acquire AMCo for $3.5bn (£2.27bn).
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
